发明名称 USE OF ADENOSINE RECEPTOR AGONIST IN THERAPY
摘要 <P>PROBLEM TO BE SOLVED: To provide an adenosine receptor agonist having a preventive, a therapeutic or an improving effect on a cancer, an inflammatory symptom, an autoimmune disease, an ischemic reperfusion disturbance, an epilepsy, an epileptic shock, a nerve degeneration (including Alzheimer disease), a muscular fatigue or a muscular spasm. <P>SOLUTION: Use of a specific 2-alkoxy adenosine substituted with an alkoxy group at a second position of a purine ring. Application of a compound shown by a formula (I) (wherein R represents 1-4C-alkoxy and X represents OH) and administered at an amount to give only a peak plasmaconcentration less than that of an EC50 value at pH 7.4 of the adenosine receptor after administration to the subject. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012111764(A) 申请公布日期 2012.06.14
申请号 JP20120001451 申请日期 2012.01.06
申请人 CBT DEVELOPMENT LTD 发明人 RICHARDSON PETER
分类号 A61K31/7076;A61P9/10;A61P21/00;A61P21/02;A61P25/08;A61P25/28;A61P29/00;A61P31/04;A61P35/00;A61P37/02;C07H19/16;C07H19/167 主分类号 A61K31/7076
代理机构 代理人
主权项
地址